![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
Reset all filters
01 5ALKERMES INC
Reset all filters
01 58796276
Reset all filters
01 5Blank
Reset all filters
01 5Blank
Reset all filters
01 52030-06-24
Patent Expiration Date : 2030-06-24
US Patent Number : 8796276
Drug Substance Claim :
Drug Product Claim :
Application Number : 207533
Patent Use Code : U-543
Delist Requested :
Patent Use Description : TREATMENT OF SCHIZOPHR...
Patent Expiration Date : 2030-06-24
Patent Expiration Date : 2030-06-24
US Patent Number : 8796276
Drug Substance Claim :
Drug Product Claim :
Application Number : 207533
Patent Use Code : U-543
Delist Requested :
Patent Use Description : TREATMENT OF SCHIZOPHR...
Patent Expiration Date : 2030-06-24
Patent Expiration Date : 2030-06-24
US Patent Number : 8796276
Drug Substance Claim :
Drug Product Claim :
Application Number : 207533
Patent Use Code : U-543
Delist Requested :
Patent Use Description : TREATMENT OF SCHIZOPHR...
Patent Expiration Date : 2030-06-24
Patent Expiration Date : 2030-06-24
US Patent Number : 8796276
Drug Substance Claim :
Drug Product Claim :
Application Number : 209830
Patent Use Code : U-543
Delist Requested :
Patent Use Description : TREATMENT OF SCHIZOPHR...
Patent Expiration Date : 2030-06-24
Patent Expiration Date : 2030-06-24
US Patent Number : 8796276
Drug Substance Claim :
Drug Product Claim :
Application Number : 207533
Patent Use Code : U-543
Delist Requested :
Patent Use Description : TREATMENT OF SCHIZOPHR...
Patent Expiration Date : 2030-06-24
LOOKING FOR A SUPPLIER?